Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias.
We report the observation and analysis of a new adverse event during the insulin tolerance test (ITT) and propose additional safety procedures. An 8-year-old girl with growth hormone insufficiency had a cardiac arrest due to ventricular flutter when she was tested for growth hormone deficiency by the ITT. Severe hypokalaemia (K+ 2.6 mmol/l) was observed after resuscitation. Ergometry ECG revealed catecholaminergic polymorphic ventricular tachycardia, a hereditary arrhythmogenic disease. Consecutive measurements of serum potassium during ITT in 29 short children (21 boys) with growth failure revealed a mean decrease of serum potassium by 1.1 +/- 0.4 mmol/l with the nadir at 30 min after the insulin bolus. Hypokalaemia (serum potassium < 3.5 mmol/l) occurred in all but one child; severe hypokalaemia (serum potassium < 2.9 mmol/l) was measured in every third child. This observation indicates that acute hypokalaemia which is induced by insulin and catecholamine excess occurs frequently in ITT. The case shows that the combination of acute hypokalaemia and the adrenergic counterregulation in ITT is a strong trigger of cardiac arrhythmias, which can become life-threatening if the child has an arrhythmogenic disease. Therefore, we recommend ECG monitoring during ITT to enhance the detection of cardiac arrhythmias. In addition, in the case of a comatose child during ITT the determination of the glucose and potassium level as well as adequate treatment are necessary.
Binder
Gerhard
G
University Children's Hospital, Tübingen, Germany. gdbinder@med.uni-tuebingen.de
Bosk
Axel
A
Gass
Matthias
M
Ranke
Michael B
MB
Heidemann
Peter H
PH
D000293:Adolescent; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000175:diagnosis; D001786:Blood Glucose; D002648:Child; D002675:Child, Preschool; D003955:Diagnostic Tests, Routine / Q000009:adverse effects*; D004393:Dwarfism, Pituitary / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D007328:Insulin / Q000009:adverse effects; D008297:Male
D001786:Blood Glucose; D007328:Insulin